Cite
Abstract 5271: Molecular imaging of pyruvate kinase M2 (PKM2) with [18F]DASA-23 detects temozolomide- and tumor treating fields (TTFields)-induced changes in glycolysis in glioblastoma
MLA
Edwin Chang, et al. “Abstract 5271: Molecular Imaging of Pyruvate Kinase M2 (PKM2) with [18F]DASA-23 Detects Temozolomide- and Tumor Treating Fields (TTFields)-Induced Changes in Glycolysis in Glioblastoma.” Cancer Research, vol. 79, July 2019, p. 5271. EBSCOhost, https://doi.org/10.1158/1538-7445.am2019-5271.
APA
Edwin Chang, Sanjiv S. Gambhir, Yuanyang Xie, Corinne Beinat, & Chirag B. Patel. (2019). Abstract 5271: Molecular imaging of pyruvate kinase M2 (PKM2) with [18F]DASA-23 detects temozolomide- and tumor treating fields (TTFields)-induced changes in glycolysis in glioblastoma. Cancer Research, 79, 5271. https://doi.org/10.1158/1538-7445.am2019-5271
Chicago
Edwin Chang, Sanjiv S. Gambhir, Yuanyang Xie, Corinne Beinat, and Chirag B. Patel. 2019. “Abstract 5271: Molecular Imaging of Pyruvate Kinase M2 (PKM2) with [18F]DASA-23 Detects Temozolomide- and Tumor Treating Fields (TTFields)-Induced Changes in Glycolysis in Glioblastoma.” Cancer Research 79 (July): 5271. doi:10.1158/1538-7445.am2019-5271.